Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Best

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
Nature Genetics|November 28, 2002
Post-analysis follow-up and validation of microarray experimentsRodrigo F Chuaqui, Robert F Bonner, Carolyn J M Best, et al.
Molecular Carcinogenesis|January 25, 2002
Proteomic analysis of human prostate cancerMamoun Ahram, Carolyn J M Best, Michael J Flaig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivoJoell J Gills, Jaclyn Lopiccolo, Junji Tsurutani, et al.
Journal of the American College of Cardiology|March 12, 2016
Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating HemodialysisLaTonya J Hickson, Sara M Negrotto, Macaulay Onuigbo, et al.
Circulation Research|December 20, 2021
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary ArteriesMichel T Corban, Takumi Toya, Diana Albers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Molecular alterations in primary prostate cancer after androgen ablation therapyCarolyn J M Best, John W Gillespie, Yajun Yi, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Nature Genetics|November 28, 2002
Post-analysis follow-up and validation of microarray experimentsRodrigo F Chuaqui, Robert F Bonner, Carolyn J M Best, et al.
Molecular Carcinogenesis|January 25, 2002
Proteomic analysis of human prostate cancerMamoun Ahram, Carolyn J M Best, Michael J Flaig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivoJoell J Gills, Jaclyn Lopiccolo, Junji Tsurutani, et al.
Journal of the American College of Cardiology|March 12, 2016
Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating HemodialysisLaTonya J Hickson, Sara M Negrotto, Macaulay Onuigbo, et al.
Circulation Research|December 20, 2021
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary ArteriesMichel T Corban, Takumi Toya, Diana Albers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Molecular alterations in primary prostate cancer after androgen ablation therapyCarolyn J M Best, John W Gillespie, Yajun Yi, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
Pageof 21